nodes	percent_of_prediction	percent_of_DWPC	metapath
Donepezil—Moexipril—Ramipril—type 2 diabetes mellitus	0.273	1	CrCrCtD
Donepezil—CYP3A4—type 2 diabetes mellitus	0.136	1	CbGaD
Donepezil—HTR2A—Bromocriptine—type 2 diabetes mellitus	0.0314	0.0865	CbGbCtD
Donepezil—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.023	0.0633	CbGbCtD
Donepezil—CYP2C9—Glipizide—type 2 diabetes mellitus	0.021	0.0579	CbGbCtD
Donepezil—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0196	0.0538	CbGbCtD
Donepezil—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0166	0.0458	CbGbCtD
Donepezil—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0166	0.0458	CbGbCtD
Donepezil—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.0153	0.0422	CbGbCtD
Donepezil—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0152	0.0419	CbGbCtD
Donepezil—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.015	0.0413	CbGbCtD
Donepezil—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.0148	0.0408	CbGbCtD
Donepezil—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.014	0.0386	CbGbCtD
Donepezil—CYP2C9—Valsartan—type 2 diabetes mellitus	0.0136	0.0373	CbGbCtD
Donepezil—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0134	0.0368	CbGbCtD
Donepezil—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.0126	0.0347	CbGbCtD
Donepezil—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0122	0.0337	CbGbCtD
Donepezil—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.0121	0.0333	CbGbCtD
Donepezil—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.0115	0.0317	CbGbCtD
Donepezil—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.011	0.0304	CbGbCtD
Donepezil—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0107	0.0294	CbGbCtD
Donepezil—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00967	0.0266	CbGbCtD
Donepezil—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00851	0.0234	CbGbCtD
Donepezil—CYP2C9—Losartan—type 2 diabetes mellitus	0.00779	0.0214	CbGbCtD
Donepezil—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00733	0.0202	CbGbCtD
Donepezil—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00703	0.0193	CbGbCtD
Donepezil—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00703	0.0193	CbGbCtD
Donepezil—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00664	0.0183	CbGbCtD
Donepezil—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00495	0.0136	CbGbCtD
Donepezil—CYP3A4—Losartan—type 2 diabetes mellitus	0.00453	0.0125	CbGbCtD
Donepezil—HTR2A—arteriole—type 2 diabetes mellitus	0.0027	0.183	CbGeAlD
Donepezil—HTR2A—sympathetic nervous system—type 2 diabetes mellitus	0.00172	0.117	CbGeAlD
Donepezil—HTR2A—autonomic nervous system—type 2 diabetes mellitus	0.00116	0.0785	CbGeAlD
Donepezil—HTR2A—hindlimb—type 2 diabetes mellitus	0.00107	0.0726	CbGeAlD
Donepezil—ACHE—islet of Langerhans—type 2 diabetes mellitus	0.000882	0.0598	CbGeAlD
Donepezil—HTR2A—peripheral nervous system—type 2 diabetes mellitus	0.000835	0.0566	CbGeAlD
Donepezil—Moexipril—ACE—type 2 diabetes mellitus	0.000691	0.504	CrCbGaD
Donepezil—Doxazosin—ADRA2A—type 2 diabetes mellitus	0.00068	0.496	CrCbGaD
Donepezil—HTR2A—artery—type 2 diabetes mellitus	0.000656	0.0445	CbGeAlD
Donepezil—HTR2A—nerve—type 2 diabetes mellitus	0.000651	0.0442	CbGeAlD
Donepezil—SIGMAR1—islet of Langerhans—type 2 diabetes mellitus	0.000592	0.0401	CbGeAlD
Donepezil—HTR2A—endothelium—type 2 diabetes mellitus	0.000554	0.0376	CbGeAlD
Donepezil—SIGMAR1—nephron tubule—type 2 diabetes mellitus	0.000476	0.0323	CbGeAlD
Donepezil—SIGMAR1—pancreas—type 2 diabetes mellitus	0.000416	0.0282	CbGeAlD
Donepezil—SIGMAR1—cortex of kidney—type 2 diabetes mellitus	0.000408	0.0277	CbGeAlD
Donepezil—SIGMAR1—adipose tissue—type 2 diabetes mellitus	0.000377	0.0256	CbGeAlD
Donepezil—CYP2C9—cardiovascular system—type 2 diabetes mellitus	0.000277	0.0188	CbGeAlD
Donepezil—HTR2A—retina—type 2 diabetes mellitus	0.000269	0.0183	CbGeAlD
Donepezil—SIGMAR1—liver—type 2 diabetes mellitus	0.000265	0.018	CbGeAlD
Donepezil—HTR2A—cardiovascular system—type 2 diabetes mellitus	0.000228	0.0155	CbGeAlD
Donepezil—HTR2A—kidney—type 2 diabetes mellitus	0.000223	0.0151	CbGeAlD
Donepezil—CYP3A4—kidney—type 2 diabetes mellitus	0.000206	0.014	CbGeAlD
Donepezil—CYP2D6—kidney—type 2 diabetes mellitus	0.000203	0.0138	CbGeAlD
Donepezil—CYP2C9—liver—type 2 diabetes mellitus	0.000171	0.0116	CbGeAlD
Donepezil—HTR2A—liver—type 2 diabetes mellitus	0.000141	0.00957	CbGeAlD
Donepezil—CYP3A4—liver—type 2 diabetes mellitus	0.000131	0.00886	CbGeAlD
Donepezil—CYP2D6—liver—type 2 diabetes mellitus	0.000128	0.00872	CbGeAlD
Donepezil—Tinnitus—Ramipril—type 2 diabetes mellitus	5.16e-05	0.000323	CcSEcCtD
Donepezil—Hypertension—Irbesartan—type 2 diabetes mellitus	5.16e-05	0.000323	CcSEcCtD
Donepezil—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	5.15e-05	0.000322	CcSEcCtD
Donepezil—Infection—Metformin—type 2 diabetes mellitus	5.13e-05	0.000321	CcSEcCtD
Donepezil—Insomnia—Valsartan—type 2 diabetes mellitus	5.13e-05	0.000321	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	5.11e-05	0.00032	CcSEcCtD
Donepezil—Paraesthesia—Valsartan—type 2 diabetes mellitus	5.09e-05	0.000319	CcSEcCtD
Donepezil—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	5.09e-05	0.000318	CcSEcCtD
Donepezil—Chest pain—Irbesartan—type 2 diabetes mellitus	5.09e-05	0.000318	CcSEcCtD
Donepezil—Arthralgia—Irbesartan—type 2 diabetes mellitus	5.09e-05	0.000318	CcSEcCtD
Donepezil—Myalgia—Irbesartan—type 2 diabetes mellitus	5.09e-05	0.000318	CcSEcCtD
Donepezil—Shock—Metformin—type 2 diabetes mellitus	5.08e-05	0.000318	CcSEcCtD
Donepezil—Insomnia—Orlistat—type 2 diabetes mellitus	5.07e-05	0.000317	CcSEcCtD
Donepezil—Malaise—Losartan—type 2 diabetes mellitus	5.07e-05	0.000317	CcSEcCtD
Donepezil—Anxiety—Irbesartan—type 2 diabetes mellitus	5.07e-05	0.000317	CcSEcCtD
Donepezil—Hypersensitivity—Glyburide—type 2 diabetes mellitus	5.07e-05	0.000317	CcSEcCtD
Donepezil—Nervous system disorder—Metformin—type 2 diabetes mellitus	5.07e-05	0.000317	CcSEcCtD
Donepezil—Thrombocytopenia—Metformin—type 2 diabetes mellitus	5.06e-05	0.000317	CcSEcCtD
Donepezil—Dyspnoea—Valsartan—type 2 diabetes mellitus	5.06e-05	0.000317	CcSEcCtD
Donepezil—Vertigo—Losartan—type 2 diabetes mellitus	5.05e-05	0.000316	CcSEcCtD
Donepezil—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	5.05e-05	0.000316	CcSEcCtD
Donepezil—Somnolence—Valsartan—type 2 diabetes mellitus	5.04e-05	0.000316	CcSEcCtD
Donepezil—Syncope—Losartan—type 2 diabetes mellitus	5.04e-05	0.000316	CcSEcCtD
Donepezil—Paraesthesia—Orlistat—type 2 diabetes mellitus	5.03e-05	0.000315	CcSEcCtD
Donepezil—Discomfort—Irbesartan—type 2 diabetes mellitus	5.02e-05	0.000315	CcSEcCtD
Donepezil—Hyperhidrosis—Metformin—type 2 diabetes mellitus	4.99e-05	0.000313	CcSEcCtD
Donepezil—Dyspepsia—Valsartan—type 2 diabetes mellitus	4.99e-05	0.000313	CcSEcCtD
Donepezil—Dizziness—Bromocriptine—type 2 diabetes mellitus	4.97e-05	0.000311	CcSEcCtD
Donepezil—Dry mouth—Irbesartan—type 2 diabetes mellitus	4.97e-05	0.000311	CcSEcCtD
Donepezil—Nausea—Glimepiride—type 2 diabetes mellitus	4.95e-05	0.00031	CcSEcCtD
Donepezil—Arrhythmia—Ramipril—type 2 diabetes mellitus	4.95e-05	0.00031	CcSEcCtD
Donepezil—Loss of consciousness—Losartan—type 2 diabetes mellitus	4.94e-05	0.000309	CcSEcCtD
Donepezil—Nausea—Sitagliptin—type 2 diabetes mellitus	4.94e-05	0.000309	CcSEcCtD
Donepezil—Dyspepsia—Orlistat—type 2 diabetes mellitus	4.93e-05	0.000309	CcSEcCtD
Donepezil—Asthenia—Glyburide—type 2 diabetes mellitus	4.93e-05	0.000309	CcSEcCtD
Donepezil—Decreased appetite—Valsartan—type 2 diabetes mellitus	4.93e-05	0.000309	CcSEcCtD
Donepezil—Anorexia—Metformin—type 2 diabetes mellitus	4.92e-05	0.000308	CcSEcCtD
Donepezil—Cough—Losartan—type 2 diabetes mellitus	4.91e-05	0.000307	CcSEcCtD
Donepezil—Urticaria—Gliclazide—type 2 diabetes mellitus	4.9e-05	0.000307	CcSEcCtD
Donepezil—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	4.9e-05	0.000307	CcSEcCtD
Donepezil—Alopecia—Ramipril—type 2 diabetes mellitus	4.89e-05	0.000306	CcSEcCtD
Donepezil—Fatigue—Valsartan—type 2 diabetes mellitus	4.89e-05	0.000306	CcSEcCtD
Donepezil—Abdominal pain—Gliclazide—type 2 diabetes mellitus	4.88e-05	0.000306	CcSEcCtD
Donepezil—Body temperature increased—Gliclazide—type 2 diabetes mellitus	4.88e-05	0.000306	CcSEcCtD
Donepezil—Oedema—Irbesartan—type 2 diabetes mellitus	4.87e-05	0.000305	CcSEcCtD
Donepezil—Decreased appetite—Orlistat—type 2 diabetes mellitus	4.87e-05	0.000305	CcSEcCtD
Donepezil—Pruritus—Glyburide—type 2 diabetes mellitus	4.86e-05	0.000305	CcSEcCtD
Donepezil—Mental disorder—Ramipril—type 2 diabetes mellitus	4.85e-05	0.000304	CcSEcCtD
Donepezil—Constipation—Valsartan—type 2 diabetes mellitus	4.85e-05	0.000304	CcSEcCtD
Donepezil—Infection—Irbesartan—type 2 diabetes mellitus	4.84e-05	0.000303	CcSEcCtD
Donepezil—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	4.84e-05	0.000303	CcSEcCtD
Donepezil—Fatigue—Orlistat—type 2 diabetes mellitus	4.83e-05	0.000303	CcSEcCtD
Donepezil—Hypotension—Metformin—type 2 diabetes mellitus	4.83e-05	0.000302	CcSEcCtD
Donepezil—Malnutrition—Ramipril—type 2 diabetes mellitus	4.82e-05	0.000302	CcSEcCtD
Donepezil—Erythema—Ramipril—type 2 diabetes mellitus	4.82e-05	0.000302	CcSEcCtD
Donepezil—Shock—Irbesartan—type 2 diabetes mellitus	4.8e-05	0.0003	CcSEcCtD
Donepezil—Pain—Orlistat—type 2 diabetes mellitus	4.79e-05	0.0003	CcSEcCtD
Donepezil—Arthralgia—Losartan—type 2 diabetes mellitus	4.79e-05	0.0003	CcSEcCtD
Donepezil—Chest pain—Losartan—type 2 diabetes mellitus	4.79e-05	0.0003	CcSEcCtD
Donepezil—Myalgia—Losartan—type 2 diabetes mellitus	4.79e-05	0.0003	CcSEcCtD
Donepezil—Vomiting—Bromocriptine—type 2 diabetes mellitus	4.78e-05	0.000299	CcSEcCtD
Donepezil—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	4.78e-05	0.000299	CcSEcCtD
Donepezil—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	4.77e-05	0.000299	CcSEcCtD
Donepezil—Anxiety—Losartan—type 2 diabetes mellitus	4.77e-05	0.000299	CcSEcCtD
Donepezil—Rash—Bromocriptine—type 2 diabetes mellitus	4.74e-05	0.000297	CcSEcCtD
Donepezil—Dermatitis—Bromocriptine—type 2 diabetes mellitus	4.74e-05	0.000297	CcSEcCtD
Donepezil—Tension—Ramipril—type 2 diabetes mellitus	4.73e-05	0.000296	CcSEcCtD
Donepezil—Discomfort—Losartan—type 2 diabetes mellitus	4.73e-05	0.000296	CcSEcCtD
Donepezil—Dysgeusia—Ramipril—type 2 diabetes mellitus	4.72e-05	0.000295	CcSEcCtD
Donepezil—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	4.71e-05	0.000295	CcSEcCtD
Donepezil—Headache—Bromocriptine—type 2 diabetes mellitus	4.71e-05	0.000295	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	4.71e-05	0.000295	CcSEcCtD
Donepezil—Diarrhoea—Glyburide—type 2 diabetes mellitus	4.7e-05	0.000295	CcSEcCtD
Donepezil—Nervousness—Ramipril—type 2 diabetes mellitus	4.68e-05	0.000293	CcSEcCtD
Donepezil—Dry mouth—Losartan—type 2 diabetes mellitus	4.68e-05	0.000293	CcSEcCtD
Donepezil—Anorexia—Irbesartan—type 2 diabetes mellitus	4.65e-05	0.000291	CcSEcCtD
Donepezil—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	4.64e-05	0.00029	CcSEcCtD
Donepezil—Paraesthesia—Metformin—type 2 diabetes mellitus	4.64e-05	0.00029	CcSEcCtD
Donepezil—Muscle spasms—Ramipril—type 2 diabetes mellitus	4.63e-05	0.00029	CcSEcCtD
Donepezil—Confusional state—Losartan—type 2 diabetes mellitus	4.63e-05	0.00029	CcSEcCtD
Donepezil—Feeling abnormal—Orlistat—type 2 diabetes mellitus	4.62e-05	0.000289	CcSEcCtD
Donepezil—Dyspnoea—Metformin—type 2 diabetes mellitus	4.61e-05	0.000288	CcSEcCtD
Donepezil—Somnolence—Metformin—type 2 diabetes mellitus	4.59e-05	0.000287	CcSEcCtD
Donepezil—Oedema—Losartan—type 2 diabetes mellitus	4.59e-05	0.000287	CcSEcCtD
Donepezil—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	4.58e-05	0.000287	CcSEcCtD
Donepezil—Infection—Losartan—type 2 diabetes mellitus	4.56e-05	0.000285	CcSEcCtD
Donepezil—Hypotension—Irbesartan—type 2 diabetes mellitus	4.56e-05	0.000285	CcSEcCtD
Donepezil—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	4.55e-05	0.000285	CcSEcCtD
Donepezil—Dyspepsia—Metformin—type 2 diabetes mellitus	4.55e-05	0.000285	CcSEcCtD
Donepezil—Tremor—Ramipril—type 2 diabetes mellitus	4.52e-05	0.000283	CcSEcCtD
Donepezil—Shock—Losartan—type 2 diabetes mellitus	4.51e-05	0.000283	CcSEcCtD
Donepezil—Urticaria—Valsartan—type 2 diabetes mellitus	4.51e-05	0.000282	CcSEcCtD
Donepezil—Nervous system disorder—Losartan—type 2 diabetes mellitus	4.5e-05	0.000282	CcSEcCtD
Donepezil—Thrombocytopenia—Losartan—type 2 diabetes mellitus	4.49e-05	0.000281	CcSEcCtD
Donepezil—Decreased appetite—Metformin—type 2 diabetes mellitus	4.49e-05	0.000281	CcSEcCtD
Donepezil—Abdominal pain—Valsartan—type 2 diabetes mellitus	4.48e-05	0.000281	CcSEcCtD
Donepezil—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	4.47e-05	0.00028	CcSEcCtD
Donepezil—Nausea—Bromocriptine—type 2 diabetes mellitus	4.47e-05	0.00028	CcSEcCtD
Donepezil—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	4.46e-05	0.000279	CcSEcCtD
Donepezil—Fatigue—Metformin—type 2 diabetes mellitus	4.45e-05	0.000279	CcSEcCtD
Donepezil—Urticaria—Orlistat—type 2 diabetes mellitus	4.45e-05	0.000279	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	4.44e-05	0.000278	CcSEcCtD
Donepezil—Hyperhidrosis—Losartan—type 2 diabetes mellitus	4.43e-05	0.000278	CcSEcCtD
Donepezil—Abdominal pain—Orlistat—type 2 diabetes mellitus	4.43e-05	0.000277	CcSEcCtD
Donepezil—Body temperature increased—Orlistat—type 2 diabetes mellitus	4.43e-05	0.000277	CcSEcCtD
Donepezil—Asthenia—Gliclazide—type 2 diabetes mellitus	4.43e-05	0.000277	CcSEcCtD
Donepezil—Agitation—Ramipril—type 2 diabetes mellitus	4.43e-05	0.000277	CcSEcCtD
Donepezil—Constipation—Metformin—type 2 diabetes mellitus	4.42e-05	0.000277	CcSEcCtD
Donepezil—Paraesthesia—Irbesartan—type 2 diabetes mellitus	4.38e-05	0.000274	CcSEcCtD
Donepezil—Anorexia—Losartan—type 2 diabetes mellitus	4.37e-05	0.000274	CcSEcCtD
Donepezil—Vomiting—Glyburide—type 2 diabetes mellitus	4.37e-05	0.000274	CcSEcCtD
Donepezil—Pruritus—Gliclazide—type 2 diabetes mellitus	4.37e-05	0.000273	CcSEcCtD
Donepezil—Malaise—Ramipril—type 2 diabetes mellitus	4.35e-05	0.000272	CcSEcCtD
Donepezil—Dyspnoea—Irbesartan—type 2 diabetes mellitus	4.35e-05	0.000272	CcSEcCtD
Donepezil—Rash—Glyburide—type 2 diabetes mellitus	4.34e-05	0.000271	CcSEcCtD
Donepezil—Somnolence—Irbesartan—type 2 diabetes mellitus	4.33e-05	0.000271	CcSEcCtD
Donepezil—Dermatitis—Glyburide—type 2 diabetes mellitus	4.33e-05	0.000271	CcSEcCtD
Donepezil—Vertigo—Ramipril—type 2 diabetes mellitus	4.33e-05	0.000271	CcSEcCtD
Donepezil—Syncope—Ramipril—type 2 diabetes mellitus	4.32e-05	0.000271	CcSEcCtD
Donepezil—Headache—Glyburide—type 2 diabetes mellitus	4.31e-05	0.00027	CcSEcCtD
Donepezil—Dyspepsia—Irbesartan—type 2 diabetes mellitus	4.29e-05	0.000269	CcSEcCtD
Donepezil—Hypotension—Losartan—type 2 diabetes mellitus	4.29e-05	0.000268	CcSEcCtD
Donepezil—Feeling abnormal—Metformin—type 2 diabetes mellitus	4.26e-05	0.000266	CcSEcCtD
Donepezil—Decreased appetite—Irbesartan—type 2 diabetes mellitus	4.24e-05	0.000265	CcSEcCtD
Donepezil—Loss of consciousness—Ramipril—type 2 diabetes mellitus	4.24e-05	0.000265	CcSEcCtD
Donepezil—Diarrhoea—Gliclazide—type 2 diabetes mellitus	4.22e-05	0.000264	CcSEcCtD
Donepezil—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	4.22e-05	0.000264	CcSEcCtD
Donepezil—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	4.21e-05	0.000263	CcSEcCtD
Donepezil—Cough—Ramipril—type 2 diabetes mellitus	4.21e-05	0.000263	CcSEcCtD
Donepezil—Fatigue—Irbesartan—type 2 diabetes mellitus	4.2e-05	0.000263	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	4.18e-05	0.000262	CcSEcCtD
Donepezil—Hypersensitivity—Valsartan—type 2 diabetes mellitus	4.18e-05	0.000262	CcSEcCtD
Donepezil—Convulsion—Ramipril—type 2 diabetes mellitus	4.18e-05	0.000261	CcSEcCtD
Donepezil—Pain—Irbesartan—type 2 diabetes mellitus	4.17e-05	0.000261	CcSEcCtD
Donepezil—Constipation—Irbesartan—type 2 diabetes mellitus	4.17e-05	0.000261	CcSEcCtD
Donepezil—Insomnia—Losartan—type 2 diabetes mellitus	4.15e-05	0.00026	CcSEcCtD
Donepezil—Hypersensitivity—Orlistat—type 2 diabetes mellitus	4.13e-05	0.000259	CcSEcCtD
Donepezil—Paraesthesia—Losartan—type 2 diabetes mellitus	4.12e-05	0.000258	CcSEcCtD
Donepezil—Urticaria—Metformin—type 2 diabetes mellitus	4.1e-05	0.000257	CcSEcCtD
Donepezil—Chest pain—Ramipril—type 2 diabetes mellitus	4.1e-05	0.000257	CcSEcCtD
Donepezil—Myalgia—Ramipril—type 2 diabetes mellitus	4.1e-05	0.000257	CcSEcCtD
Donepezil—Arthralgia—Ramipril—type 2 diabetes mellitus	4.1e-05	0.000257	CcSEcCtD
Donepezil—Dyspnoea—Losartan—type 2 diabetes mellitus	4.09e-05	0.000256	CcSEcCtD
Donepezil—Anxiety—Ramipril—type 2 diabetes mellitus	4.09e-05	0.000256	CcSEcCtD
Donepezil—Nausea—Glyburide—type 2 diabetes mellitus	4.08e-05	0.000256	CcSEcCtD
Donepezil—Abdominal pain—Metformin—type 2 diabetes mellitus	4.08e-05	0.000256	CcSEcCtD
Donepezil—Dizziness—Gliclazide—type 2 diabetes mellitus	4.08e-05	0.000256	CcSEcCtD
Donepezil—Somnolence—Losartan—type 2 diabetes mellitus	4.08e-05	0.000255	CcSEcCtD
Donepezil—Asthenia—Valsartan—type 2 diabetes mellitus	4.07e-05	0.000255	CcSEcCtD
Donepezil—Discomfort—Ramipril—type 2 diabetes mellitus	4.05e-05	0.000254	CcSEcCtD
Donepezil—Dyspepsia—Losartan—type 2 diabetes mellitus	4.04e-05	0.000253	CcSEcCtD
Donepezil—Asthenia—Orlistat—type 2 diabetes mellitus	4.02e-05	0.000252	CcSEcCtD
Donepezil—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	4.02e-05	0.000251	CcSEcCtD
Donepezil—Pruritus—Valsartan—type 2 diabetes mellitus	4.01e-05	0.000251	CcSEcCtD
Donepezil—Dry mouth—Ramipril—type 2 diabetes mellitus	4.01e-05	0.000251	CcSEcCtD
Donepezil—Decreased appetite—Losartan—type 2 diabetes mellitus	3.99e-05	0.00025	CcSEcCtD
Donepezil—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	3.99e-05	0.00025	CcSEcCtD
Donepezil—Confusional state—Ramipril—type 2 diabetes mellitus	3.97e-05	0.000248	CcSEcCtD
Donepezil—Pruritus—Orlistat—type 2 diabetes mellitus	3.97e-05	0.000248	CcSEcCtD
Donepezil—Fatigue—Losartan—type 2 diabetes mellitus	3.96e-05	0.000248	CcSEcCtD
Donepezil—Oedema—Ramipril—type 2 diabetes mellitus	3.93e-05	0.000246	CcSEcCtD
Donepezil—Vomiting—Gliclazide—type 2 diabetes mellitus	3.93e-05	0.000246	CcSEcCtD
Donepezil—Pain—Losartan—type 2 diabetes mellitus	3.92e-05	0.000246	CcSEcCtD
Donepezil—Constipation—Losartan—type 2 diabetes mellitus	3.92e-05	0.000246	CcSEcCtD
Donepezil—Rash—Gliclazide—type 2 diabetes mellitus	3.89e-05	0.000244	CcSEcCtD
Donepezil—Dermatitis—Gliclazide—type 2 diabetes mellitus	3.89e-05	0.000243	CcSEcCtD
Donepezil—Diarrhoea—Valsartan—type 2 diabetes mellitus	3.88e-05	0.000243	CcSEcCtD
Donepezil—Urticaria—Irbesartan—type 2 diabetes mellitus	3.87e-05	0.000242	CcSEcCtD
Donepezil—Shock—Ramipril—type 2 diabetes mellitus	3.87e-05	0.000242	CcSEcCtD
Donepezil—Headache—Gliclazide—type 2 diabetes mellitus	3.87e-05	0.000242	CcSEcCtD
Donepezil—Nervous system disorder—Ramipril—type 2 diabetes mellitus	3.86e-05	0.000241	CcSEcCtD
Donepezil—Abdominal pain—Irbesartan—type 2 diabetes mellitus	3.85e-05	0.000241	CcSEcCtD
Donepezil—Body temperature increased—Irbesartan—type 2 diabetes mellitus	3.85e-05	0.000241	CcSEcCtD
Donepezil—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	3.85e-05	0.000241	CcSEcCtD
Donepezil—Diarrhoea—Orlistat—type 2 diabetes mellitus	3.83e-05	0.00024	CcSEcCtD
Donepezil—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	3.8e-05	0.000238	CcSEcCtD
Donepezil—Feeling abnormal—Losartan—type 2 diabetes mellitus	3.78e-05	0.000237	CcSEcCtD
Donepezil—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	3.75e-05	0.000235	CcSEcCtD
Donepezil—Dizziness—Valsartan—type 2 diabetes mellitus	3.75e-05	0.000235	CcSEcCtD
Donepezil—Anorexia—Ramipril—type 2 diabetes mellitus	3.75e-05	0.000235	CcSEcCtD
Donepezil—Dizziness—Orlistat—type 2 diabetes mellitus	3.71e-05	0.000232	CcSEcCtD
Donepezil—Asthenia—Metformin—type 2 diabetes mellitus	3.71e-05	0.000232	CcSEcCtD
Donepezil—Hypotension—Ramipril—type 2 diabetes mellitus	3.68e-05	0.00023	CcSEcCtD
Donepezil—Nausea—Gliclazide—type 2 diabetes mellitus	3.67e-05	0.00023	CcSEcCtD
Donepezil—Pruritus—Metformin—type 2 diabetes mellitus	3.65e-05	0.000229	CcSEcCtD
Donepezil—Urticaria—Losartan—type 2 diabetes mellitus	3.64e-05	0.000228	CcSEcCtD
Donepezil—Body temperature increased—Losartan—type 2 diabetes mellitus	3.63e-05	0.000227	CcSEcCtD
Donepezil—Abdominal pain—Losartan—type 2 diabetes mellitus	3.63e-05	0.000227	CcSEcCtD
Donepezil—Vomiting—Valsartan—type 2 diabetes mellitus	3.61e-05	0.000226	CcSEcCtD
Donepezil—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	3.59e-05	0.000225	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	3.58e-05	0.000224	CcSEcCtD
Donepezil—Rash—Valsartan—type 2 diabetes mellitus	3.58e-05	0.000224	CcSEcCtD
Donepezil—Dermatitis—Valsartan—type 2 diabetes mellitus	3.57e-05	0.000224	CcSEcCtD
Donepezil—Vomiting—Orlistat—type 2 diabetes mellitus	3.56e-05	0.000223	CcSEcCtD
Donepezil—Insomnia—Ramipril—type 2 diabetes mellitus	3.56e-05	0.000223	CcSEcCtD
Donepezil—Headache—Valsartan—type 2 diabetes mellitus	3.55e-05	0.000222	CcSEcCtD
Donepezil—Diarrhoea—Metformin—type 2 diabetes mellitus	3.53e-05	0.000221	CcSEcCtD
Donepezil—Rash—Orlistat—type 2 diabetes mellitus	3.53e-05	0.000221	CcSEcCtD
Donepezil—Paraesthesia—Ramipril—type 2 diabetes mellitus	3.53e-05	0.000221	CcSEcCtD
Donepezil—Dermatitis—Orlistat—type 2 diabetes mellitus	3.53e-05	0.000221	CcSEcCtD
Donepezil—Headache—Orlistat—type 2 diabetes mellitus	3.51e-05	0.00022	CcSEcCtD
Donepezil—Dyspnoea—Ramipril—type 2 diabetes mellitus	3.51e-05	0.00022	CcSEcCtD
Donepezil—Asthenia—Irbesartan—type 2 diabetes mellitus	3.5e-05	0.000219	CcSEcCtD
Donepezil—Somnolence—Ramipril—type 2 diabetes mellitus	3.5e-05	0.000219	CcSEcCtD
Donepezil—Dyspepsia—Ramipril—type 2 diabetes mellitus	3.46e-05	0.000217	CcSEcCtD
Donepezil—Pruritus—Irbesartan—type 2 diabetes mellitus	3.45e-05	0.000216	CcSEcCtD
Donepezil—Decreased appetite—Ramipril—type 2 diabetes mellitus	3.42e-05	0.000214	CcSEcCtD
Donepezil—Dizziness—Metformin—type 2 diabetes mellitus	3.42e-05	0.000214	CcSEcCtD
Donepezil—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	3.4e-05	0.000213	CcSEcCtD
Donepezil—Fatigue—Ramipril—type 2 diabetes mellitus	3.39e-05	0.000212	CcSEcCtD
Donepezil—Hypersensitivity—Losartan—type 2 diabetes mellitus	3.38e-05	0.000212	CcSEcCtD
Donepezil—Nausea—Valsartan—type 2 diabetes mellitus	3.37e-05	0.000211	CcSEcCtD
Donepezil—Constipation—Ramipril—type 2 diabetes mellitus	3.36e-05	0.000211	CcSEcCtD
Donepezil—Diarrhoea—Irbesartan—type 2 diabetes mellitus	3.34e-05	0.000209	CcSEcCtD
Donepezil—Nausea—Orlistat—type 2 diabetes mellitus	3.33e-05	0.000208	CcSEcCtD
Donepezil—Asthenia—Losartan—type 2 diabetes mellitus	3.29e-05	0.000206	CcSEcCtD
Donepezil—Vomiting—Metformin—type 2 diabetes mellitus	3.28e-05	0.000206	CcSEcCtD
Donepezil—Rash—Metformin—type 2 diabetes mellitus	3.26e-05	0.000204	CcSEcCtD
Donepezil—Dermatitis—Metformin—type 2 diabetes mellitus	3.25e-05	0.000204	CcSEcCtD
Donepezil—Pruritus—Losartan—type 2 diabetes mellitus	3.25e-05	0.000203	CcSEcCtD
Donepezil—Feeling abnormal—Ramipril—type 2 diabetes mellitus	3.24e-05	0.000203	CcSEcCtD
Donepezil—Headache—Metformin—type 2 diabetes mellitus	3.24e-05	0.000203	CcSEcCtD
Donepezil—Dizziness—Irbesartan—type 2 diabetes mellitus	3.22e-05	0.000202	CcSEcCtD
Donepezil—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	3.22e-05	0.000201	CcSEcCtD
Donepezil—Diarrhoea—Losartan—type 2 diabetes mellitus	3.14e-05	0.000196	CcSEcCtD
Donepezil—Urticaria—Ramipril—type 2 diabetes mellitus	3.12e-05	0.000196	CcSEcCtD
Donepezil—Abdominal pain—Ramipril—type 2 diabetes mellitus	3.11e-05	0.000195	CcSEcCtD
Donepezil—Body temperature increased—Ramipril—type 2 diabetes mellitus	3.11e-05	0.000195	CcSEcCtD
Donepezil—Vomiting—Irbesartan—type 2 diabetes mellitus	3.1e-05	0.000194	CcSEcCtD
Donepezil—Rash—Irbesartan—type 2 diabetes mellitus	3.07e-05	0.000192	CcSEcCtD
Donepezil—Dermatitis—Irbesartan—type 2 diabetes mellitus	3.07e-05	0.000192	CcSEcCtD
Donepezil—Nausea—Metformin—type 2 diabetes mellitus	3.07e-05	0.000192	CcSEcCtD
Donepezil—Headache—Irbesartan—type 2 diabetes mellitus	3.05e-05	0.000191	CcSEcCtD
Donepezil—Dizziness—Losartan—type 2 diabetes mellitus	3.03e-05	0.00019	CcSEcCtD
Donepezil—Vomiting—Losartan—type 2 diabetes mellitus	2.92e-05	0.000183	CcSEcCtD
Donepezil—Hypersensitivity—Ramipril—type 2 diabetes mellitus	2.9e-05	0.000181	CcSEcCtD
Donepezil—Nausea—Irbesartan—type 2 diabetes mellitus	2.9e-05	0.000181	CcSEcCtD
Donepezil—Rash—Losartan—type 2 diabetes mellitus	2.89e-05	0.000181	CcSEcCtD
Donepezil—Dermatitis—Losartan—type 2 diabetes mellitus	2.89e-05	0.000181	CcSEcCtD
Donepezil—Headache—Losartan—type 2 diabetes mellitus	2.87e-05	0.00018	CcSEcCtD
Donepezil—Asthenia—Ramipril—type 2 diabetes mellitus	2.82e-05	0.000177	CcSEcCtD
Donepezil—Pruritus—Ramipril—type 2 diabetes mellitus	2.78e-05	0.000174	CcSEcCtD
Donepezil—Nausea—Losartan—type 2 diabetes mellitus	2.72e-05	0.000171	CcSEcCtD
Donepezil—Diarrhoea—Ramipril—type 2 diabetes mellitus	2.69e-05	0.000168	CcSEcCtD
Donepezil—Dizziness—Ramipril—type 2 diabetes mellitus	2.6e-05	0.000163	CcSEcCtD
Donepezil—Vomiting—Ramipril—type 2 diabetes mellitus	2.5e-05	0.000157	CcSEcCtD
Donepezil—Rash—Ramipril—type 2 diabetes mellitus	2.48e-05	0.000155	CcSEcCtD
Donepezil—Dermatitis—Ramipril—type 2 diabetes mellitus	2.48e-05	0.000155	CcSEcCtD
Donepezil—Headache—Ramipril—type 2 diabetes mellitus	2.46e-05	0.000154	CcSEcCtD
Donepezil—Nausea—Ramipril—type 2 diabetes mellitus	2.34e-05	0.000146	CcSEcCtD
Donepezil—ACHE—Metabolism—APOE—type 2 diabetes mellitus	7.08e-06	0.000136	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—AGT—type 2 diabetes mellitus	7.07e-06	0.000136	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	7.02e-06	0.000134	CbGpPWpGaD
Donepezil—ACHE—Metabolism—APOA1—type 2 diabetes mellitus	7e-06	0.000134	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—EDNRA—type 2 diabetes mellitus	6.98e-06	0.000134	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—CALM1—type 2 diabetes mellitus	6.96e-06	0.000133	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CYBA—type 2 diabetes mellitus	6.95e-06	0.000133	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—SRC—type 2 diabetes mellitus	6.85e-06	0.000131	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ALDOB—type 2 diabetes mellitus	6.85e-06	0.000131	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	6.83e-06	0.000131	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	6.81e-06	0.00013	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PLAT—type 2 diabetes mellitus	6.81e-06	0.00013	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—GHRL—type 2 diabetes mellitus	6.81e-06	0.00013	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ALDOB—type 2 diabetes mellitus	6.79e-06	0.00013	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CALCA—type 2 diabetes mellitus	6.72e-06	0.000129	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.67e-06	0.000128	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	6.63e-06	0.000127	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	6.63e-06	0.000127	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	6.59e-06	0.000126	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	6.54e-06	0.000125	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	6.46e-06	0.000124	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	6.46e-06	0.000124	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	6.39e-06	0.000122	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GLP1R—type 2 diabetes mellitus	6.37e-06	0.000122	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	6.33e-06	0.000121	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GLP1R—type 2 diabetes mellitus	6.31e-06	0.000121	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	6.3e-06	0.000121	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—GCG—type 2 diabetes mellitus	6.22e-06	0.000119	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PTPN1—type 2 diabetes mellitus	6.22e-06	0.000119	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PPARG—type 2 diabetes mellitus	6.16e-06	0.000118	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	6.16e-06	0.000118	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	6.16e-06	0.000118	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	6.16e-06	0.000118	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.13e-06	0.000117	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	6.12e-06	0.000117	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	6.1e-06	0.000117	CbGpPWpGaD
Donepezil—ACHE—Metabolism—INS—type 2 diabetes mellitus	6.05e-06	0.000116	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.01e-06	0.000115	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—SLC2A2—type 2 diabetes mellitus	5.94e-06	0.000114	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	5.91e-06	0.000113	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	5.91e-06	0.000113	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—SLC2A2—type 2 diabetes mellitus	5.89e-06	0.000113	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—CCL2—type 2 diabetes mellitus	5.83e-06	0.000112	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CPT1A—type 2 diabetes mellitus	5.82e-06	0.000112	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—MTR—type 2 diabetes mellitus	5.82e-06	0.000112	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CPT1A—type 2 diabetes mellitus	5.77e-06	0.000111	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—MTR—type 2 diabetes mellitus	5.77e-06	0.000111	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—AKT2—type 2 diabetes mellitus	5.72e-06	0.00011	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	5.72e-06	0.00011	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—NAMPT—type 2 diabetes mellitus	5.71e-06	0.000109	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	5.69e-06	0.000109	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	5.69e-06	0.000109	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—LIPC—type 2 diabetes mellitus	5.67e-06	0.000109	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—HBA1—type 2 diabetes mellitus	5.67e-06	0.000109	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GCK—type 2 diabetes mellitus	5.67e-06	0.000109	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—NAMPT—type 2 diabetes mellitus	5.66e-06	0.000108	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	5.64e-06	0.000108	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	5.63e-06	0.000108	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—LIPC—type 2 diabetes mellitus	5.63e-06	0.000108	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—HBA1—type 2 diabetes mellitus	5.63e-06	0.000108	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GCK—type 2 diabetes mellitus	5.63e-06	0.000108	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CYP11A1—type 2 diabetes mellitus	5.59e-06	0.000107	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	5.59e-06	0.000107	CbGpPWpGaD
Donepezil—ACHE—Metabolism—ALB—type 2 diabetes mellitus	5.54e-06	0.000106	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	5.54e-06	0.000106	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	5.49e-06	0.000105	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	5.49e-06	0.000105	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	5.49e-06	0.000105	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	5.49e-06	0.000105	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	5.47e-06	0.000105	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	5.43e-06	0.000104	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	5.42e-06	0.000104	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—GNB3—type 2 diabetes mellitus	5.36e-06	0.000103	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PIK3R1—type 2 diabetes mellitus	5.3e-06	0.000102	CbGpPWpGaD
Donepezil—ACHE—Metabolism—NOS3—type 2 diabetes mellitus	5.3e-06	0.000102	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—AVP—type 2 diabetes mellitus	5.29e-06	0.000101	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MMP3—type 2 diabetes mellitus	5.29e-06	0.000101	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—IGF2—type 2 diabetes mellitus	5.27e-06	0.000101	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	5.25e-06	0.000101	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	5.19e-06	9.95e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	5.16e-06	9.9e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—APOB—type 2 diabetes mellitus	5.12e-06	9.8e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—IGF1R—type 2 diabetes mellitus	5.09e-06	9.76e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	5.09e-06	9.75e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	5.09e-06	9.75e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	5.09e-06	9.75e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	5.06e-06	9.7e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	5.05e-06	9.67e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	5.05e-06	9.67e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	5.05e-06	9.67e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—EDN1—type 2 diabetes mellitus	5.03e-06	9.65e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	5e-06	9.57e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	4.95e-06	9.49e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	4.95e-06	9.49e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	4.91e-06	9.41e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—LPL—type 2 diabetes mellitus	4.88e-06	9.36e-05	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PTGS2—type 2 diabetes mellitus	4.85e-06	9.29e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	4.85e-06	9.28e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	4.84e-06	9.28e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	4.84e-06	9.27e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	4.8e-06	9.2e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—ADCY5—type 2 diabetes mellitus	4.78e-06	9.16e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	4.67e-06	8.95e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	4.67e-06	8.95e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	4.67e-06	8.95e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	4.67e-06	8.95e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	4.66e-06	8.92e-05	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—IL6—type 2 diabetes mellitus	4.62e-06	8.85e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	4.62e-06	8.84e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	4.6e-06	8.82e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	4.6e-06	8.82e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	4.58e-06	8.78e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	4.56e-06	8.74e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	4.56e-06	8.74e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CCR5—type 2 diabetes mellitus	4.5e-06	8.62e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	4.49e-06	8.6e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	4.48e-06	8.58e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	4.45e-06	8.53e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.43e-06	8.48e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	4.41e-06	8.46e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	4.41e-06	8.46e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—C3—type 2 diabetes mellitus	4.4e-06	8.43e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	4.37e-06	8.38e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	4.37e-06	8.38e-05	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.26e-06	8.16e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	4.19e-06	8.04e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—IRS2—type 2 diabetes mellitus	4.18e-06	8.02e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—AGT—type 2 diabetes mellitus	4.18e-06	8.01e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	4.16e-06	7.98e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CALM1—type 2 diabetes mellitus	4.11e-06	7.87e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—LEP—type 2 diabetes mellitus	4.09e-06	7.84e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—APOE—type 2 diabetes mellitus	4.09e-06	7.84e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—APOA1—type 2 diabetes mellitus	4.05e-06	7.75e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	3.89e-06	7.45e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.86e-06	7.4e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	3.81e-06	7.29e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	3.81e-06	7.29e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.8e-06	7.29e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	3.8e-06	7.29e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	3.79e-06	7.25e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	3.77e-06	7.23e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.77e-06	7.23e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	3.75e-06	7.19e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	3.74e-06	7.16e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	3.73e-06	7.15e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	3.71e-06	7.11e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	3.71e-06	7.11e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	3.71e-06	7.11e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	3.7e-06	7.1e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	3.69e-06	7.07e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—IRS1—type 2 diabetes mellitus	3.65e-06	7e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	3.63e-06	6.95e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	3.62e-06	6.94e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	3.6e-06	6.89e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	3.58e-06	6.86e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	3.53e-06	6.76e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—INS—type 2 diabetes mellitus	3.5e-06	6.7e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	3.5e-06	6.7e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	3.46e-06	6.64e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.44e-06	6.59e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	3.43e-06	6.58e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	3.39e-06	6.5e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.38e-06	6.48e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.38e-06	6.48e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	3.38e-06	6.47e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.37e-06	6.45e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	3.36e-06	6.44e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	3.35e-06	6.42e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	3.33e-06	6.38e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	3.33e-06	6.38e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	3.33e-06	6.38e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	3.29e-06	6.3e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	3.27e-06	6.26e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	3.26e-06	6.25e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	3.25e-06	6.23e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	3.24e-06	6.2e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	3.22e-06	6.17e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.21e-06	6.16e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	3.17e-06	6.07e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	3.12e-06	5.97e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	3.09e-06	5.92e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.07e-06	5.88e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.07e-06	5.88e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	3.06e-06	5.86e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	3.04e-06	5.83e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	3.03e-06	5.81e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	3.01e-06	5.77e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	3.01e-06	5.77e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	2.96e-06	5.68e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	2.94e-06	5.63e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	2.91e-06	5.58e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	2.9e-06	5.56e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	2.89e-06	5.53e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—RELA—type 2 diabetes mellitus	2.89e-06	5.53e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	2.89e-06	5.53e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	2.89e-06	5.53e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	2.88e-06	5.51e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	2.87e-06	5.5e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	2.84e-06	5.45e-05	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.63e-06	5.04e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.6e-06	4.99e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.59e-06	4.96e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	2.53e-06	4.84e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	2.51e-06	4.8e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.49e-06	4.76e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.49e-06	4.76e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	2.48e-06	4.75e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.48e-06	4.74e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.46e-06	4.72e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	2.46e-06	4.71e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.44e-06	4.68e-05	CbGpPWpGaD
Donepezil—ACHE—Metabolism—AKT1—type 2 diabetes mellitus	2.44e-06	4.67e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.43e-06	4.67e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.39e-06	4.57e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.37e-06	4.54e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.31e-06	4.42e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	2.27e-06	4.36e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—SRC—type 2 diabetes mellitus	2.27e-06	4.35e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.26e-06	4.34e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	2.25e-06	4.32e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.22e-06	4.25e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.21e-06	4.23e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.21e-06	4.23e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	2.17e-06	4.17e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	2.17e-06	4.17e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	2.16e-06	4.13e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	2.16e-06	4.13e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.15e-06	4.12e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.12e-06	4.07e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2.04e-06	3.91e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.03e-06	3.89e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2e-06	3.83e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	1.99e-06	3.81e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.99e-06	3.81e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	1.97e-06	3.78e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.94e-06	3.71e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.9e-06	3.65e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.9e-06	3.64e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.88e-06	3.59e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.65e-06	3.17e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.62e-06	3.11e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—IL6—type 2 diabetes mellitus	1.53e-06	2.93e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.49e-06	2.85e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.42e-06	2.72e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.42e-06	2.72e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.41e-06	2.7e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.3e-06	2.49e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	1e-06	1.92e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	9.91e-07	1.9e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	6.54e-07	1.25e-05	CbGpPWpGaD
